VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
ALGNAlign Technology, Inc.
$182.08$13.0B
Research
OverviewAnalysis
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist

ALGN logoAlign Technology, Inc.(ALGN)Earnings, Financials & Key Ratios

ALGN•NASDAQ
32.2× P/E·Price updated Jun 19, 2026
SectorHealthcareIndustryMedical DevicesSub-IndustryVision, dental, and ENT devices
AboutAlign Technology, Inc., a medical device company, designs, manufactures, and markets Invisalign clear aligners and iTero intraoral scanners and services for orthodontists and general practitioner dentists, and restorative and aesthetic dentistry. It operates in two segments, Clear Aligner; and Scanners and Services. The Clear Aligner segment consists of comprehensive products, including Invisalign comprehensive treatment that addresses the orthodontic needs of teenage patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of seven and ten years, which is a mixture of primary/baby and permanent teeth. This segment's non-comprehensive products comprise Invisalign moderate, lite and express packages, and Invisalign go; and non-case products include retention products, Invisalign training fees, and sales of ancillary products, such as cleaning material, and adjusting tools used by dental professionals during the course of treatment. The Scanners and Services segment offers iTero scanner, a single hardware platform with software options for restorative or orthodontic procedures; restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons; and software for orthodontists for digital records storage, orthodontic diagnosis, and for the fabrication of printed models and retainers. This segment also provides computer-aided design and computer-aided manufacturing services; ancillary products, such as disposable sleeves for the wand; iTero model and dies; third party scanners and digital scans; Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; and TimeLapse technology, which allows doctors or practitioners to compare a patient's historic 3D scans to the present-day scan. The company sells its products in the United States, Switzerland, China, and internationally. Align Technology, Inc. was incorporated in 1997 and is headquartered in Tempe, Arizona.Show more
  • Revenue$4.03B+0.9%
  • EBITDA$797M+5.9%
  • Net Income$410M-2.6%
  • EPS (Diluted)5.65+0.5%
  • Gross Margin68.33%-2.4%
  • EBITDA Margin19.75%+4.9%
  • Operating Margin15.27%+0.5%
  • Net Margin10.17%-3.5%
  • ROE10.39%-7.8%

ALGN Key Insights

Align Technology, Inc. (ALGN) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

  • ✓Company is almost debt free
  • ✓Strong Piotroski F-Score: 7/9
  • ✓High quality earnings: Operating CF exceeds net income
  • ✓Strong 5Y sales CAGR of 10.3%
  • ✓Share count reduced 3.2% through buybacks
  • ✓Healthy 5Y average net margin of 12.3%

✗Weaknesses

  • ✗Profits declining 25.4% over 5 years

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

Get notified when ALGN posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

ALGN Price & Volume

Align Technology, Inc. (ALGN) stock price & volume — 10-year historical chart

Loading chart...

ALGN Growth Metrics

Align Technology, Inc. (ALGN) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years16.92%
5 Years10.3%
3 Years2.61%
TTM2.89%

Profit CAGR

10 Years11.04%
5 Years-25.4%
3 Years4.31%
TTM4.96%

EPS CAGR

10 Years12.31%
5 Years-24.09%
3 Years7.02%
TTM8.56%

Return on Capital

10 Years23.18%
5 Years17.46%
3 Years15.12%
Last Year14.52%

ALGN Recent Earnings

Align Technology, Inc. (ALGN) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat EPS 10/12 qtrs (83%)●Beat Revenue 7/12 qtrs (58%)
Q2 2026Latest
Apr 29, 2026
Metric
Actual
Est
EPS
$2.58+14.2%
$2.26
Rev
$1.0B+1.8%
$1.0B
Q1 2026
Feb 4, 2026
Metric
Actual
Est
EPS
$3.29+10.0%
$2.99
Rev
$1.0B+1.4%
$1.0B
Q4 2025
Oct 29, 2025
Metric
Actual
Est
EPS
$2.61+8.8%
$2.40
Rev
$996M+2.0%
$976M
Q3 2025
Jul 30, 2025
Metric
Actual
Est
EPS
$2.49-3.1%
$2.57
Rev
$1.0B-0.9%
$1.0B
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q2 2026LatestApr 29, 2026
$2.58vs $2.26+14.2%
$1.0Bvs $1.0B+1.8%
Q1 2026Feb 4, 2026
$3.29vs $2.99+10.0%
$1.0Bvs $1.0B+1.4%
Q4 2025Oct 29, 2025
$2.61vs $2.40+8.8%
$996Mvs $976M+2.0%
Q3 2025Jul 30, 2025
$2.49vs $2.57-3.1%
$1.0Bvs $1.0B-0.9%
Based on last 12 quarters of dataView full earnings history →

ALGN Peer Comparison

Align Technology, Inc. (ALGN) competitors in Vision, dental, and ENT devices — business model, growth, and fundamentals comparison

Select Columns
Stock Universe
Valuation
Growth
Profitability
Financial Health
Dividends & Buybacks
Price Performance
Technical
Fundamentals ($)
Sector-Specific
Institutional Holdings
CompanyMarket CapStock PriceP/E Ratio (TTM)Revenue Growth 1YNet MarginReturn on Equity (ROE)FCF YieldDebt / Equity
XRAY logoXRAYDENTSPLY SIRONA Inc.Direct Competitor2.07B10.33-3.44-2.98%-17.06%-41.19%1.84
HSIC logoHSICHenry Schein, Inc.Direct Competitor9.17B79.9224.444.03%3.02%8.24%0.77
NVST logoNVSTEnvista Holdings CorpDirect Competitor4.22B25.9192.548.32%2.41%2.18%0.55
IDXX logoIDXXIDEXX Laboratories, Inc.Product Competitor44.64B562.0942.9710.42%24.63%70.87%0.67
HOLX logoHOLXHologic, Inc.Product Competitor16.97B76.0130.531.74%13.18%11.01%0.52
ISRG logoISRGIntuitive Surgical, Inc.Product Competitor144.48B406.7851.6920.51%28.15%16.89%0.02
GKOS logoGKOSGlaukos CorporationProduct Competitor7.65B130.68-39.8432.33%-34.34%-26.46%0.21
TMDX logoTMDXTransMedics Group, Inc.Product Competitor2.72B78.7916.1837.13%27.04%41.92%0.99

Compare ALGN vs Peers

Align Technology, Inc. (ALGN) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs XRAY

Most directly comparable listed peer for ALGN.

Scale Benchmark

vs ISRG

Larger-name benchmark to compare ALGN against a more recognizable public peer.

Peer Set

Compare Top 5

vs XRAY, HSIC, NVST, IDXX

ALGN Income Statement

Align Technology, Inc. (ALGN) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily
MetricDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Sales/Revenue
1.47B1.97B2.41B2.47B3.95B3.73B3.86B4B4.03B4.1B
Revenue Growth %
36.44%33.47%22.39%2.71%59.9%-5.51%3.42%3.54%0.9%2.89%
Cost of Goods Sold
356.47M518.63M662.9M708.71M1.02B1.1B1.16B1.2B1.28B1.32B
COGS % of Revenue
24.19%26.37%27.54%28.67%25.74%29.48%29.92%30%31.67%-
Gross Profit
1.12B▲ 0%
1.45B▲ 29.6%
1.74B▲ 20.4%
1.76B▲ 1.1%
2.94B▲ 66.5%
2.63B▼ 10.3%
2.71B▲ 2.8%
2.8B▲ 3.4%
2.76B▼ 1.5%
2.77B▲ 0%
Gross Margin %
75.81%73.63%72.46%71.33%74.26%70.52%70.08%70%68.33%67.68%
Gross Profit Growth %
37%29.63%20.45%1.11%66.48%-10.27%2.77%3.41%-1.51%-
Operating Expenses
763.34M981.3M1.2B1.38B1.96B1.99B2.06B2.19B2.14B2.18B
OpEx % of Revenue
51.81%49.9%49.92%55.67%49.56%53.32%53.43%54.8%53.05%-
Selling, General & Admin
665.78M852.4M1.07B1.2B1.71B1.67B1.7B1.76B1.76B1.77B
SG&A % of Revenue
45.19%43.35%44.54%48.58%43.23%44.84%44.1%44.09%43.51%-
Research & Development
97.56M128.9M157.36M175.31M250.31M305.26M346.83M364.2M369.91M371.37M
R&D % of Revenue
6.62%6.55%6.54%7.09%6.33%8.17%8.98%9.11%9.17%-
Other Operating Expenses
00-28.01M0011.45M13.32M64.14M14.98M2M
Operating Income
353.61M▲ 0%
466.56M▲ 31.9%
542.49M▲ 16.3%
387.17M▼ 28.6%
976.4M▲ 152.2%
642.6M▼ 34.2%
643.34M▲ 0.1%
607.63M▼ 5.6%
616.22M▲ 1.4%
591.59M▲ 0%
Operating Margin %
24%23.73%22.54%15.66%24.7%17.21%16.66%15.19%15.27%14.44%
Operating Income Growth %
42.06%31.94%16.27%-28.63%152.19%-34.19%0.12%-5.55%1.41%-
EBITDA
391.35M521.29M621.48M480.71M1.09B768.39M785.74M752.66M796.8M789.86M
EBITDA Margin %
26.56%26.51%25.82%19.45%27.45%20.57%20.34%18.82%19.75%19.28%
EBITDA Growth %
43.39%33.2%19.22%-22.65%125.74%-29.19%2.26%-4.21%5.86%7.34%
D&A (Non-Cash Add-back)
37.74M54.73M78.99M93.54M108.73M125.79M142.4M145.03M180.59M198.27M
EBIT
353.61M466.56M514.48M387.17M976.4M654.05M656.65M671.76M585.29M608.59M
Net Interest Income
6.95M8.58M12.48M3.13M3.1M5.37M17.26M20.22M16.05M13.08M
Interest Income
6.95M8.58M12.48M3.13M3.1M5.37M17.26M20.22M16.05M14.64M
Interest Expense
0000000001.56M
Other Income/Expense
11.19M-8.61M12.63M-8.22M36.02M-43.54M-2.13M1.33M-30.93M2.14M
Pretax Income
364.8M▲ 0%
457.96M▲ 25.5%
555.12M▲ 21.2%
378.95M▼ 31.7%
1.01B▲ 167.2%
599.06M▼ 40.8%
641.2M▲ 7.0%
608.96M▼ 5.0%
585.29M▼ 3.9%
593.73M▲ 0%
Pretax Margin %
24.76%23.29%23.06%15.33%25.61%16.04%16.6%15.23%14.51%14.5%
Income Tax
130.16M57.72M112.35M-1.4B240.4M237.48M196.15M187.6M174.94M163.84M
Effective Tax Rate %
35.68%12.6%20.24%-368.64%23.75%39.64%30.59%30.81%29.89%27.59%
Net Income
231.42M▲ 0%
400.24M▲ 72.9%
442.78M▲ 10.6%
1.78B▲ 301.1%
772.02M▼ 56.5%
361.57M▼ 53.2%
445.05M▲ 23.1%
421.36M▼ 5.3%
410.35M▼ 2.6%
429.89M▲ 0%
Net Margin %
15.71%20.35%18.4%71.84%19.53%9.68%11.52%10.54%10.17%10.5%
Net Income Growth %
22%72.95%10.63%301.08%-56.53%-53.17%23.09%-5.32%-2.61%4.96%
Net Income (Continuing)
231.42M400.24M442.78M1.78B772.02M361.57M445.05M421.36M410.35M429.89M
Discontinued Operations
0000000000
Minority Interest
0000000000
EPS (Diluted)
2.83▲ 0%
4.92▲ 73.9%
5.53▲ 12.4%
22.41▲ 305.2%
9.69▼ 56.8%
4.61▼ 52.4%
5.81▲ 26.0%
5.62▼ 3.3%
5.65▲ 0.5%
6.00▲ 0%
EPS Growth %
21.46%73.85%12.4%305.24%-56.76%-52.43%26.03%-3.27%0.53%8.56%
EPS (Basic)
2.895.005.5722.559.784.625.825.635.66-
Diluted Shares Outstanding
81.83M81.36M80.1M79.23M79.67M78.42M76.57M74.99M72.59M71.61M
Basic Shares Outstanding
80.08M80.06M79.42M78.76M78.92M78.19M76.43M74.88M72.54M71.42M
Dividend Payout Ratio
----------

ALGN Balance Sheet

Align Technology, Inc. (ALGN) balance sheet — assets, liabilities & shareholders' equity

MetricDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Total Current Assets
1.16B1.3B1.63B1.85B2.49B2.42B2.45B2.49B2.62B2.66B
Cash & Short-Term Investments
721.54M735.36M868.63M960.84M1.17B999.58M972.74M1.04B1.09B1.06B
Cash Only
449.51M636.9M550.42M960.84M1.1B942.05M937.44M1.04B1.08B1.06B
Short-Term Investments
272.03M98.46M318.2M071.97M57.53M35.3M015.92M0
Accounts Receivable
324.19M482.31M616.55M657.7M990.81M1B1.05B1.03B1.16B1.13B
Days Sales Outstanding
80.3189.5293.597.1191.597.7598.9693.98104.71101.95
Inventory
31.69M55.64M112.05M139.24M230.23M338.75M296.9M254.29M226.34M214.94M
Days Inventory Outstanding
32.4539.1661.771.7182.61112.3293.7977.3664.6462.95
Other Current Assets
0024.42M61.69M31.48M16.76M77.33M81.58M75.26M255.54M
Total Non-Current Assets
620.85M749.98M867.28M2.98B3.45B3.52B3.64B3.72B3.62B3.66B
Property, Plant & Equipment
348.79M521.33M687.97M817.27M1.2B1.35B1.41B1.38B1.24B1.22B
Fixed Asset Turnover
4.22x3.77x3.50x3.02x3.29x2.76x2.74x2.89x3.25x3.19x
Goodwill
64.61M64.03M63.92M444.82M418.55M407.55M419.53M442.63M491.83M503.04M
Intangible Assets
24.45M17.92M11.77M130.07M109.71M95.72M82.12M103.49M93.93M100.82M
Long-Term Investments
94.55M64.89M5.89M0125.32M41.98M8.02M000
Other Non-Current Assets
38.38M17.13M33.72M35.15M57.51M55.83M128.68M234.16M278.05M365.14M
Total Assets
1.78B▲ 0%
2.05B▲ 15.4%
2.5B▲ 21.8%
4.83B▲ 93.1%
5.94B▲ 23.0%
5.95B▲ 0.1%
6.08B▲ 2.3%
6.21B▲ 2.1%
6.23B▲ 0.3%
6.31B▲ 0%
Asset Turnover
0.83x0.96x0.96x0.51x0.67x0.63x0.63x0.64x0.65x0.66x
Asset Growth %
27.34%15.45%21.84%93.13%23.03%0.1%2.29%2.15%0.31%2.68%
Total Current Liabilities
497.82M692.07M970.97M1.33B1.92B1.93B2.07B2.04B1.92B1.91B
Accounts Payable
36.78M64.26M87.25M142.13M163.89M127.87M113.13M108.69M121.45M123.72M
Days Payables Outstanding
37.6645.2248.0473.258.8142.435.7433.0634.6833.44
Short-Term Debt
0000000031.94M0
Deferred Revenue (Current)
273.09M393.14M563.76M777.89M1.15B1.34B1.43B1.33B1.26B5.11B
Other Current Liabilities
5.06M101.82M127.61M183.61M262.4M203.97M237.16M0234.61M546.88M
Current Ratio
2.32x1.88x1.68x1.40x1.30x1.26x1.18x1.22x1.36x1.39x
Quick Ratio
2.26x1.80x1.57x1.29x1.18x1.08x1.04x1.10x1.24x1.28x
Cash Conversion Cycle
75.183.46107.1695.62115.3167.67157.02138.27134.67131.46
Total Non-Current Liabilities
129.67M107.49M183.56M270.22M395.32M420.7M386.78M324.59M264.53M258.9M
Long-Term Debt
0000000000
Capital Lease Obligations
0043.46M64.44M102.66M100.33M96.97M88.21M82.51M343.68M
Deferred Tax Liabilities
0000000000
Other Non-Current Liabilities
129.67M107.49M140.1M205.77M292.67M320.37M289.81M236.37M182.02M175.48M
Total Liabilities
627.49M799.57M1.15B1.6B2.32B2.35B2.45B2.36B2.18B2.16B
Total Debt
0059.2M86.18M125.38M126.91M126.62M119.28M114.45M83.42M
Net Debt
-449.51M-636.9M-491.23M-874.66M-974M-815.14M-810.82M-924.61M-964.54M-976.41M
Debt / Equity
--0.04x0.03x0.03x0.04x0.03x0.03x0.03x0.02x
Debt / EBITDA
--0.10x0.18x0.12x0.17x0.16x0.16x0.14x0.11x
Net Debt / EBITDA
-1.15x-1.22x-0.79x-1.82x-0.90x-1.06x-1.03x-1.23x-1.21x-1.24x
Interest Coverage
---------389.13x
Total Equity
1.15B▲ 0%
1.25B▲ 8.9%
1.35B▲ 7.4%
3.23B▲ 140.2%
3.62B▲ 12.0%
3.6B▼ 0.6%
3.63B▲ 0.8%
3.85B▲ 6.1%
4.05B▲ 5.1%
4.15B▲ 0%
Equity Growth %
15.57%8.91%7.45%140.23%12.02%-0.59%0.81%6.1%5.12%18.93%
Book Value per Share
14.0615.4016.8140.8245.4745.9247.4251.3655.7857.94
Total Shareholders' Equity
1.15B1.25B1.35B3.23B3.62B3.6B3.63B3.85B4.05B4.15B
Common Stock
8K8K8K8K8K8K7K7K7K0
Retained Earnings
263.36M378.14M439.91M2.22B2.62B2.57B2.45B2.48B2.46B0
Treasury Stock
0000000000
Accumulated OCI
571K-2.77M-688K43.5M4.33M-10.28M21.17M5.98M75.39M0
Minority Interest
0000000000

ALGN Cash Flow Statement

Align Technology, Inc. (ALGN) cash flow — operating, investing & free cash flow history

MetricDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Cash from Operations
438.54M554.68M747.27M662.17M1.17B568.73M785.78M738.23M593.22M691.59M
Operating CF Margin %
29.76%28.21%31.05%26.79%29.67%15.23%20.34%18.46%14.7%-
Operating CF Growth %
77.08%26.48%34.72%-11.39%77.07%-51.5%38.16%-6.05%-19.64%116.82%
Net Income
231.42M400.24M442.78M1.78B772.02M361.57M445.05M421.36M410.35M429.89M
Depreciation & Amortization
37.74M54.73M78.99M93.54M108.73M125.79M142.4M145.03M237.44M118.55M
Stock-Based Compensation
58.85M70.76M88.18M98.43M114.34M133.37M154.03M173.7M0140.87M
Deferred Taxes
17.57M-15.68M307K-1.49B15.46M-39.49M-18.64M25.76M33.09M161K
Other Non-Cash Items
17.07M25.95M61.8M56.21M7.77M71.81M70.83M44.81M268.37M404.47M
Working Capital Changes
75.89M18.69M75.21M129.69M154.24M-84.31M-7.89M-72.43M-356.01M-185.23M
Change in Receivables
-90.99M-109.22M-121.01M-139.78M-262.07M21.55M-104.61M-153.49M-139.91M-74.61M
Change in Inventory
-5.48M-24.11M-58.27M-29.11M-112.45M-130.1M30.17M25.05M808K-6.59M
Change in Payables
8.18M25.05M22.1M52.21M19.75M-36.52M-7.7M-843K5.33M-3.25M
Cash from Investing
-248.31M6.93M-350.44M-231.51M-563.43M-213.32M-195.94M-254.91M-112.44M-218.74M
Capital Expenditures
-195.69M-223.31M-149.71M-154.92M-401.1M-291.9M-177.72M-115.58M-102.44M72.06M
CapEx % of Revenue
13.28%11.36%6.22%6.27%10.15%7.82%4.6%2.89%2.54%1.76%
Acquisitions
-21.72M-5M0-420.79M-8M-12.3M-77M-183.42M00
Investments
----------
Other Investing
-29.43M30.77M7.12M28.08M-417K-2.21M278K235K0-290.79M
Cash from Financing
-135.5M-369.43M-485.54M-30.81M-458.33M-501.69M-598.34M-355.72M-464.58M-305.95M
Debt Issued (Net)
00-45.77M0000000
Equity Issued (Net)
-89.33M-283.37M-382.09M20.31M-349.42M-408.89M-565.76M-327.6M-444.19M-181.51M
Dividends Paid
0000000000
Share Repurchases
-103.79M-300M-400M0-375.04M-435.04M-592.36M-352.88M-465.94M-189.35M
Other Financing
-46.17M-86.07M-57.67M-51.12M-108.92M-92.8M-32.58M-28.13M-20.39M-124.44M
Net Change in Cash
60.24M▲ 0%
187.44M▲ 211.2%
-86.43M▼ 146.1%
410.34M▲ 574.8%
138.66M▼ 66.2%
-157.78M▼ 213.8%
-3.84M▲ 97.6%
106.44M▲ 2874.9%
51.22M▼ 51.9%
187.06M▲ 0%
Free Cash Flow
242.84M▲ 0%
331.37M▲ 36.5%
597.56M▲ 80.3%
507.26M▼ 15.1%
771.45M▲ 52.1%
276.83M▼ 64.1%
608.06M▲ 119.6%
622.65M▲ 2.4%
490.78M▼ 21.2%
716.88M▲ 0%
FCF Margin %
16.48%16.85%24.83%20.52%19.52%7.41%15.74%15.57%12.16%17.5%
FCF Growth %
37.14%36.45%80.33%-15.11%52.08%-64.12%119.65%2.4%-21.18%13.66%
FCF per Share
2.974.077.466.409.683.537.948.306.7610.01
FCF Conversion (FCF/Net Income)
1.90x1.39x1.69x0.37x1.52x1.57x1.77x1.75x1.45x1.67x
Interest Paid
0000000000
Taxes Paid
51.23M0076.33M203.31M231.88M294.57M177.08M00

ALGN Key Ratios

Align Technology, Inc. (ALGN) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric201720182019202020212022202320242025TTM
Return on Equity (ROE)
21.57%33.31%34.07%77.55%22.52%10.01%12.31%11.26%10.39%10.7%
Return on Invested Capital (ROIC)
40.58%53.15%55.32%18.07%29.25%17.74%17.21%15.86%15.37%14.24%
Gross Margin
75.81%73.63%72.46%71.33%74.26%70.52%70.08%70%68.33%67.68%
Net Margin
15.71%20.35%18.4%71.84%19.53%9.68%11.52%10.54%10.17%10.5%
Debt / Equity
--0.04x0.03x0.03x0.04x0.03x0.03x0.03x0.02x
Interest Coverage
---------389.13x
FCF Conversion
1.90x1.39x1.69x0.37x1.52x1.57x1.77x1.75x1.45x1.67x
Revenue Growth
36.44%33.47%22.39%2.71%59.9%-5.51%3.42%3.54%0.9%2.89%
Related:ALGN Dividend History·ALGN Revenue History·ALGN Price History·ALGN P/E History·ALGN Financial Ratios·ALGN Institutional Holders

ALGN SEC Filings & Documents

Align Technology, Inc. (ALGN) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

Apr 29, 2026·SEC

Material company update

Feb 26, 2026·SEC

Material company update

Feb 4, 2026·SEC

10-K Annual Reports

4
FY 2026

Feb 27, 2026·SEC

FY 2025

Feb 28, 2025·SEC

FY 2024

Feb 28, 2024·SEC

10-Q Quarterly Reports

6
FY 2025

Nov 5, 2025·SEC

FY 2025

Aug 6, 2025·SEC

FY 2025

May 8, 2025·SEC

ALGN Frequently Asked Questions

Align Technology, Inc. (ALGN) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

Align Technology, Inc. (ALGN) reported $4.10B in revenue for fiscal year 2025. This represents a 996442% increase from $0.4M in 1999.

Align Technology, Inc. (ALGN) grew revenue by 0.9% over the past year. Growth has been modest.

Yes, Align Technology, Inc. (ALGN) is profitable, generating $429.9M in net income for fiscal year 2025 (10.2% net margin).

Dividend & Returns

Align Technology, Inc. (ALGN) has a return on equity (ROE) of 10.4%. This is reasonable for most industries.

Align Technology, Inc. (ALGN) generated $716.9M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

What if you invested $1,000 in ALGN back in 1999?

Total return calculator · dividends reinvested · 27+ years of data

See returns →

How much would $100/month in ALGN be worth today?

Dollar cost averaging calculator · DCA vs lump sum

Calculate →